Xiaoning Q. He
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Health inequality aversion in China: Public and decision-maker views.
Journal: Social science & medicine (1982)
Published: February 04, 2026
Moderate and Severe Exacerbations and Healthcare Resource Utilization in Chinese Patients with COPD on Triple Therapy: A Retrospective Database Study.
Journal: Advances in therapy
Published: February 03, 2026
Retrospective Real-World Comparison of Adherence, Persistence, Health-Care Utilization, and Costs Among Biologics for Moderate-to-Severe Psoriasis in China.
Journal: Clinical drug investigation
Published: September 16, 2025
The Social Distribution of Quality-Adjusted Life Expectancy Among Social Deprivation Subgroups in China.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: July 15, 2025
Cost-Effectiveness Analysis of PI3K Inhibitors for Relapsed or Refractory Follicular Lymphoma in China: A Comparison Between Linperlisib and Duvelisib.
Journal: Clinical drug investigation
Published: June 24, 2025
Medication management, health outcomes, and economic burden of severe asthma stratified by asthma control levels.
Journal: Heart & lung : the journal of critical care
Published: May 27, 2025
Impact of moderate and severe exacerbations on clinical prognosis and economic burden of chronic obstructive pulmonary disease in China.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: May 18, 2025
Entecavir for children and adults with chronic hepatitis B.
Journal: The Cochrane database of systematic reviews
Published: April 22, 2025
Adagrasib in the treatment of KRASG12C-mutated non-small cell lung cancer: a cost-effectiveness analysis.
Journal: Translational cancer research
Published: April 08, 2025
How Does Disease Severity Affect Clinical Outcomes and Economic Burden of Patients with COPD -- A Retrospective Population-Based Cohort Study in Tianjin, China.
Journal: International journal of chronic obstructive pulmonary disease
Published: March 25, 2025
Matching-adjusted indirect comparison and cost-effectiveness of mitoxantrone hydrochloride liposome versus Chidamide in relapsed or refractory peripheral T-cell lymphoma in China.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: March 20, 2025
Cost-effectiveness analysis of trilaciclib for reducing the incidence of chemotherapy-induced myelosuppression among patients with extensive-stage small cell lung cancer in China.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: March 10, 2025
Last Updated: 09/26/2026